PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-324.18
Negative P/E while Healthcare median is -0.37. Seth Klarman would scrutinize path to profitability versus peers.
No Data
No Data available this quarter, please select a different quarter.
539.96
P/B exceeding 1.5x Healthcare median of 2.98. Jim Chanos would check for potential asset write-down risks.
-14885.60
Negative FCF while Healthcare median P/FCF is -0.52. Seth Klarman would investigate cash flow improvement potential.
-14885.60
Negative operating cash flow while Healthcare median P/OCF is 0.00. Seth Klarman would investigate operational improvement potential.
539.96
Fair value ratio exceeding 1.5x Healthcare median of 2.98. Jim Chanos would check for valuation bubble risks.
-0.08%
Negative earnings while Healthcare median yield is -0.15%. Seth Klarman would investigate path to profitability.
-0.01%
Negative FCF while Healthcare median yield is -0.02%. Seth Klarman would investigate cash flow improvement potential.
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40